Literature DB >> 28774406

Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants.

Chih-Lin Lin1, Jia-Horng Kao2.   

Abstract

Molecular epidemiologic studies reveal remarkable differences in the geographical distribution of hepatitis B virus (HBV) genotypes. The frequency of mutants among HBV genotypes also varies. The role of HBV genotypes/mutants in the pathogenesis of HBV infection and natural history of HBV infection has been extensively investigated. The distribution of HBV genotypes in acute hepatitis B patients reflects the predominant genotypes in a given geographic area. In chronic hepatitis B patients, genotype C and D have a higher frequency of basal core promoter A1762T/G1764A mutations than genotype A and B. HBV genotypes C, D and F carry a higher lifetime risk of cirrhosis and HCC development than genotype A and B. HBV pre-S/S gene mutations were associated with immune escape of hepatitis B immunoglobulin or vaccine-induced immunity. Mutations in the pre-S, core promoter and X regions correlate with an increased risk of cirrhosis and HCC. In summary, HBV genotypes and mutants are associated with the disease progression and long-term outcome of HBV infection. They may serve as viral genetic markers for risk stratification of chronic hepatitis B patients in clinical practice.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic hepatitis B; Cirrhosis; Genotype; HBV mutant; Hepatitis B virus (HBV); Hepatocellular carcinoma

Mesh:

Year:  2017        PMID: 28774406     DOI: 10.1016/j.bpg.2017.04.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  45 in total

1.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

Review 2.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

Review 3.  Global HBV burden: guesstimates and facts.

Authors:  Dina Ginzberg; Robert J Wong; Robert Gish
Journal:  Hepatol Int       Date:  2018-07-27       Impact factor: 6.047

Review 4.  Current perspectives into the evaluation and management of hepatitis B: a review.

Authors:  Vignan Manne; Eric Gochanour; Kris V Kowdley
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

Review 5.  Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Authors:  Mindie H Nguyen; Grace Wong; Edward Gane; Jia-Horng Kao; Geoffrey Dusheiko
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

6.  Hepatitis B virus infection and 1q21 amplification in multiple myeloma.

Authors:  Dan Guo; Peipei Xu; Chaoyang Guan; Yong Xu; Yonggong Yang; Jingyan Xu; Rongfu Zhou; Bing Chen
Journal:  Oncol Lett       Date:  2019-09-27       Impact factor: 2.967

7.  Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.

Authors:  Tao Chen; Zhongyuan Yang; Ashok Kumar Choudhury; Mamun Al Mahtab; Jun Li; Yu Chen; Soek-Siam Tan; Tao Han; Jinhua Hu; Saeed S Hamid; Lee Guan Huei; Hasmik Ghazinian; Yuemin Nan; Yogesh K Chawla; Man-Fung Yuen; Harshad Devarbhavi; Akash Shukla; Zaigham Abbas; Manoj Sahu; A K Dokmeci; Laurentias A Lesmana; Cosmas Rinaldi A Lesmana; Shaojie Xin; Zhongping Duan; Wei Guo; Ke Ma; Zhongwei Zhang; Qiuyu Cheng; Jidong Jia; B C Sharma; Shiv Kumar Sarin; Qin Ning
Journal:  Hepatol Int       Date:  2019-10-24       Impact factor: 6.047

Review 8.  Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance.

Authors:  Sheng-Han Wang; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 9.  Recent Advances in Hepatitis B Treatment.

Authors:  Georgia-Myrto Prifti; Dimitrios Moianos; Erofili Giannakopoulou; Vasiliki Pardali; John E Tavis; Grigoris Zoidis
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

10.  Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study.

Authors:  Eleanor Barnes; Philippa C Matthews; Tingyan Wang; David A Smith; Cori Campbell; Jolynne Mokaya; Oliver Freeman; Hizni Salih; Anna L McNaughton; Sarah Cripps; Kinga A Várnai; Theresa Noble; Kerrie Woods; Jane Collier; Katie Jeffery; Jim Davies
Journal:  BMC Infect Dis       Date:  2021-06-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.